Health
Prince of Songkla University Reports High Success Rate in CAR-T Cell Therapy
The Faculty of Medicine at Prince of Songkla University has announced significant progress in its locally developed CAR-T cell therapy, reporting a 90% remission rate for specific conditions.
According to a report by Khaosod English on August 4, 2026, the Faculty of Medicine at Prince of Songkla University (PSU) has shared updates regarding its locally developed CAR-T cell therapy. This medical advancement is currently being utilized to treat blood cancers and certain autoimmune diseases.
Asst. Prof. Dr. Nalinee Kowitwanawong, the deputy dean for administration at the Faculty of Medicine, stated that nearly 90% of patients treated with this therapy have achieved complete remission. This development represents a notable step in Thailand’s domestic medical research capabilities.
For residents and expatriates in Thailand, this news highlights the growing sophistication of local medical facilities in handling complex health conditions. While the reported success rate is high, it is important to note that this is a specialized treatment protocol. Patients or those seeking medical care should consult with qualified oncologists or medical professionals to understand if such therapies are applicable to their specific health circumstances.
As of now, further details regarding the broader availability of this treatment, the specific types of blood cancers covered, and the long-term clinical data remain to be confirmed by the university. Interested parties are encouraged to monitor official announcements from Prince of Songkla University for updates on the accessibility and clinical scope of this therapy.
Translated from Thai.
SawaLife is not a news organisation. We classify and translate source material using automated processing and editorial controls; the original publication remains the authoritative context.